Suppression of hepatitis B surface antigen production by combination therapy with nucleotide analogues and interferon in children with genotype C hepatitis B virus infection-Reference-Cited by-同舟云学术

Suppression of hepatitis B surface antigen production by combination therapy with nucleotide analogues and interferon in children with genotype C hepatitis B virus infection

Published:2018-08-09 Issue:13 Volume:48 Page:1172-1177
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Tajiri Hitoshi¹,Takano Tomoko¹,Tanaka Yasuhito²,Murakami Jun³,Brooks Stephen⁴

Affiliation:

1. Department of Pediatrics; Osaka General Medical Center; Osaka

2. Department of Virology and Liver Unit; Nagoya City University Graduate School of Medical Sciences; Nagoya

3. Division of Pediatrics and Perinatology; Tottori University; Yonago Japan

4. Department of Microbiology/Immunology; State University of New York at Buffalo; Buffalo New York USA

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.13227/fullpdf

Reference9 articles.

1. Treatment of children with chronic hepatitis B virus infection in the United States: patient selection and therapeutic options;Jonas;Hepatology,2010

2. Natural history of chronic hepatitis B virus infection in childhood and efficacy of interferon therapy;Takano;Scand J Gastroenterol,2015

3. Combination of tenofovir disoproxil fumarate and peginterferon α-2a increases loss of hepatitis B surface antigen in patients with chronic hepatitis B;Marcellin;Gastroenterology,2016

4. Natural history of chronic hepatitis B virus infection in children in Japan: a comparison of mother-to-child transmission with horizontal transmission;Takano;J Gastroenterol,2017

5. Classification of chronic hepatitis: diagnosis, grading and staging;Desmet;Hepatology,1994

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expert Consensus on the Prevention and Treatment of Chronic Hepatitis B in Children;Infectious Diseases & Immunity;2024-06-12

2. Dynamic evaluation of liver fibrosis to assess hepatocellular carcinoma risk in patients with chronic hepatitis B receiving nucleoside analogs treatment;Revista do Instituto de Medicina Tropical de São Paulo;2024

3. The effectiveness of combination therapy with interferon and nucleoside analogs in pediatric patients with chronic hepatitis B: a systematic review and meta-analysis;Hepatology International;2022-12-05

4. Dynamic evaluation of hepatocellular carcinoma prediction models in patients with chronic hepatitis B receiving nucleotide/nucleoside analogue treatment;Journal of Viral Hepatitis;2021-02-10

5. The efficacy of addition of Tenofovir Disoproxil Fumarate to Peg-IFNα-2b is superior to the addition of Entecavir in HBeAg positive CHB patients with a poor response after 12 weeks of Peg-IFNα-2b treatment alone;International Journal of Medical Sciences;2020